The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review

L E Kristensen, R Christensen, H Bliddal, P Geborek, B Danneskiold-Samsøe, T Saxne

    51 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review'. Together they form a unique fingerprint.

    Medicine & Life Sciences